WHO ICTRP trial

Study on the effectiveness and safety of the treatment of hyponatremia due to…

EUCTR2012-004071-39-IT · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2012-004071-39-IT
Public title Study on the effectiveness and safety of the treatment of hyponatremia due to inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients affected by pituitary disorders.
Scientific title Study on the effectiveness and safety of the treatment of mild-moderate symptomatic hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone (SIADH) with Tolvaptan vs fluid restriction in patients who underwent transsphenoidal surgery for hypothalamic-pituitary disorders.
Primary sponsor FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Countries Italy
Conditions Mild-moderate symptomatic hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone (SIADH) MedDRA version: 14.1 Level: SOC Classification code 10014698 Term: Endocrine disorders System Organ Class: 10014698…
Interventions Trade Name: SAMSCA*10CPR 15MG Pharmaceutical Form: Tablet INN or Proposed INN: TOLVAPTAN CAS Number: 150683-30-0 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 15-
Registration date Oct 31, 2012
Secondary IDs TOLV2012
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations